Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for HIV-Associated Cognitive Impairment
NCT00361257Phase 2Terminated
- Start
- Mar 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in HIV-associated cognitive impairment comparing Minocycline with Placebo (2 arms). Primary endpoint: Change in Cognitive Performance Compared to Baseline at 24 weeks. Started Mar 2007; status: terminated.
02
Drugs
minocycline
03
Conditions
HIV-associated cognitive impairment
Beyond the preview
Go deeper on NCT00361257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361257.